200,000+ products from a single source!
sales@angenechem.com
CAS No: 1269440-17-6 Catalog No: AG000WF7 MDL No:MFCD25976758
| Title | Journal |
|---|---|
| Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial. | The Lancet. Oncology 20180501 |
© 2019 Angene International Limited. All rights Reserved.